688253 英诺特
已收盘 07-01 15:00:01
资讯
新帖
简况
英诺特（688253）披露公司及子公司近期获得资质情况的自愿披露公告，6月29日股价上涨1.17%
证券之星 · 06-29 18:01
英诺特（688253）披露公司及子公司近期获得资质情况的自愿披露公告，6月29日股价上涨1.17%
英诺特：公司2025年年度业绩说明会已于2026年5月13日以上证路演中心网络互动方式召开
证券之星 · 06-03
英诺特：公司2025年年度业绩说明会已于2026年5月13日以上证路演中心网络互动方式召开
每周股票复盘：英诺特（688253）2025年度股东会多项议案获通过
证券之星 · 05-24
每周股票复盘：英诺特（688253）2025年度股东会多项议案获通过
英诺特（688253）披露2025年年度股东会决议公告，5月22日股价下跌0.08%
证券之星 · 05-22
英诺特（688253）披露2025年年度股东会决议公告，5月22日股价下跌0.08%
英诺特（688253）披露2025年度持续督导跟踪报告，5月18日股价上涨1.02%
证券之星 · 05-18
英诺特（688253）披露2025年度持续督导跟踪报告，5月18日股价上涨1.02%
每周股票复盘：英诺特（688253）2026年一季度营收利润下降
证券之星 · 05-17
每周股票复盘：英诺特（688253）2026年一季度营收利润下降
股市必读：英诺特（688253）5月13日披露最新机构调研信息
证券之星 · 05-14
股市必读：英诺特（688253）5月13日披露最新机构调研信息
每周股票复盘：英诺特（688253）股东户数下降10.44%
证券之星 · 05-02
每周股票复盘：英诺特（688253）股东户数下降10.44%
英诺特（688253）披露2025年度募集资金存放、管理与实际使用情况专项报告，4月28日股价上涨1.17%
证券之星 · 04-28
英诺特（688253）披露2025年度募集资金存放、管理与实际使用情况专项报告，4月28日股价上涨1.17%
图解英诺特一季报：第一季度单季净利润同比下降57.36%
证券之星 · 04-28
图解英诺特一季报：第一季度单季净利润同比下降57.36%
每周股票复盘：英诺特（688253）获偏肺病毒检测试剂注册证
证券之星 · 03-08
每周股票复盘：英诺特（688253）获偏肺病毒检测试剂注册证
英诺特最新公告：公司新取得一项产品资质
证券之星 · 03-05
英诺特最新公告：公司新取得一项产品资质
英诺特(688253.SH)2025年度归母净利润1.46亿元 同比下降40.84%
智通财经 · 02-11
英诺特(688253.SH)2025年度归母净利润1.46亿元 同比下降40.84%
英诺特（688253）6764.75万股限售股将于1月28日解禁，占总股本49.38%
证券之星 · 01-28
英诺特（688253）6764.75万股限售股将于1月28日解禁，占总股本49.38%
每周股票复盘：英诺特（688253）49.3834%限售股1月28日上市
证券之星 · 01-25
每周股票复盘：英诺特（688253）49.3834%限售股1月28日上市
英诺特（688253）披露首次公开发行限售股上市流通公告，1月19日股价下跌0.48%
证券之星 · 01-19
英诺特（688253）披露首次公开发行限售股上市流通公告，1月19日股价下跌0.48%
每周股票复盘：英诺特（688253）预计2026年日常关联交易额600万元
证券之星 · 01-18
每周股票复盘：英诺特（688253）预计2026年日常关联交易额600万元
英诺特（688253）披露预计2026年度日常关联交易额度，1月15日股价下跌2.55%
证券之星 · 01-15
英诺特（688253）披露预计2026年度日常关联交易额度，1月15日股价下跌2.55%
每周股票复盘：英诺特（688253）获数字化单分子免疫分析仪资质
证券之星 · 01-11
每周股票复盘：英诺特（688253）获数字化单分子免疫分析仪资质
英诺特（688253）披露近期获得资质情况，1月8日股价上涨2.26%
证券之星 · 01-08
英诺特（688253）披露近期获得资质情况，1月8日股价上涨2.26%
加载更多
公司概况
公司名称：
北京英诺特生物技术股份有限公司
所属行业：
医药制造业
上市日期：
2022-07-28
主营业务：
北京英诺特生物技术股份有限公司的主营业务是POCT快速诊断产品研发、生产和销售。公司的主要产品是呼吸道系列、优生优育系列、其他试剂系列、POCT诊断仪器。公司获得了国家级专精特新“小巨人”企业称号。
发行价格：
26.06
{"stockData":{"symbol":"688253","market":"SH","secType":"STK","nameCN":"英诺特","latestPrice":64.74,"timestamp":1782889201000,"preClose":60.28,"halted":0,"volume":2951298,"delay":0,"changeRate":0.074,"floatShares":137000000,"shares":137000000,"eps":0.6557,"marketStatus":"已收盘","change":4.46,"latestTime":"07-01 15:00:01","open":59.84,"high":66.2,"low":59.84,"amount":190000000,"amplitude":0.1055,"askPrice":64.74,"askSize":15,"bidPrice":64.7,"bidSize":2,"shortable":0,"etf":0,"ttmEps":0.6557,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1782955800000},"marketStatusCode":5,"adr":0,"adjPreClose":60.28,"symbolType":"stock_kcb","openAndCloseTimeList":[[1782869400000,1782876600000],[1782882000000,1782889200000]],"highLimit":66.31,"lowLimit":54.25,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":136984316,"isCdr":false,"pbRate":4.23,"roa":"--","peRate":98.734177,"roe":"1.96%","epsLYR":1.06,"committee":-0.075472,"marketValue":8868000000,"turnoverRate":0.0215,"status":0,"afterMarket":{"amount":0,"volume":0,"close":64.74,"buyVolume":0,"sellVolume":0,"time":1782891237746,"indexStatus":"已收盘 07-01 15:30:00","preClose":60.28},"floatMarketCap":8868000000},"requestUrl":"/m/hq/s/688253","defaultTab":"news","newsList":[{"id":"2647786183","title":"英诺特（688253）披露公司及子公司近期获得资质情况的自愿披露公告，6月29日股价上涨1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647786183","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647786183?lang=zh_cn&edition=full","pubTime":"2026-06-29 18:01","pubTimestamp":1782727274,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，英诺特报收于58.68元，较前一交易日上涨1.17%，最新总市值为80.38亿元。该股当日开盘57.7元，最高59.02元，最低55.8元，成交额达1.21亿元，换手率为1.54%。近日，北京英诺特生物技术股份有限公司及子公司近期获得6项产品资质，包括1项缅甸产品文号和5项中国医疗器械注册证。上述资质有助于提升公司市场拓展能力与核心竞争力，但实际销售及业绩影响存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900028703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640746019","title":"英诺特：公司2025年年度业绩说明会已于2026年5月13日以上证路演中心网络互动方式召开","url":"https://stock-news.laohu8.com/highlight/detail?id=2640746019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640746019?lang=zh_cn&edition=full","pubTime":"2026-06-03 15:37","pubTimestamp":1780472252,"startTime":"0","endTime":"0","summary":"证券之星消息，英诺特06月03日在投资者关系平台上答复投资者关心的问题。投资者提问：您好，我注意到贵公司在2024年未提供业绩说明会视频回放。公司2025年年度业绩说明会已于2026年5月13日以上证路演中心网络互动方式召开，具体会议内容请详见公司披露的《英诺特2026年5月13日投资者关系活动记录表》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060300026580.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637373478","title":"每周股票复盘：英诺特（688253）2025年度股东会多项议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2637373478","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637373478?lang=zh_cn&edition=full","pubTime":"2026-05-24 02:52","pubTimestamp":1779562331,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：英诺特2025年年度股东会审议通过利润分配方案、续聘审计机构及修订公司章程等议案。公司公告汇总北京市中伦律师事务所就北京英诺特生物技术股份有限公司2025年年度股东会的合法性出具法律意见书。北京英诺特生物技术股份有限公司于2026年5月21日召开2025年年度股东会，会议由董事长叶逢光主持，出席会议的股东及代理人共50人，代表有表决权股份总数的55.3957%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052400000741.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637339076","title":"英诺特（688253）披露2025年年度股东会决议公告，5月22日股价下跌0.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2637339076","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637339076?lang=zh_cn&edition=full","pubTime":"2026-05-22 17:36","pubTimestamp":1779442585,"startTime":"0","endTime":"0","summary":"截至2026年5月22日收盘，英诺特报收于65.5元，较前一交易日下跌0.08%，最新总市值为89.72亿元。英诺特于近日披露《2025年年度股东会决议公告》。公告显示，公司于2026年5月21日召开2025年年度股东会，会议由董事长叶逢光主持，出席会议的股东及代理人共50人，代表有表决权股份总数的55.3957%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200032974.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636247700","title":"英诺特（688253）披露2025年度持续督导跟踪报告，5月18日股价上涨1.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2636247700","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636247700?lang=zh_cn&edition=full","pubTime":"2026-05-18 18:23","pubTimestamp":1779099793,"startTime":"0","endTime":"0","summary":"截至2026年5月18日收盘，英诺特报收于60.65元，较前一交易日上涨1.02%，最新总市值为83.08亿元。该股当日开盘59.6元，最高61.21元，最低58.5元，成交额达1.61亿元，换手率为1.96%。近日，华泰联合证券有限责任公司发布了关于北京英诺特生物技术股份有限公司2025年度持续督导跟踪报告。2025年公司营业收入为42,203.03万元，同比下降32.08%；归属于母公司所有者的净利润为14,447.33万元，同比下降41.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051800029459.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636061482","title":"每周股票复盘：英诺特（688253）2026年一季度营收利润下降","url":"https://stock-news.laohu8.com/highlight/detail?id=2636061482","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636061482?lang=zh_cn&edition=full","pubTime":"2026-05-17 02:17","pubTimestamp":1778955430,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，英诺特报收于60.04元，较上周的50.66元上涨18.52%。本周关注点来自业绩披露要点：2026年一季度营收和利润均下降，主要受行业政策、竞争及呼吸道疾病流行减弱影响。公司公告汇总华泰联合证券有限责任公司发布了关于北京英诺特生物技术股份有限公司2025年度持续督导跟踪报告。2025年公司营业收入为42,203.03万元，同比下降32.08%；归属于母公司所有者的净利润为14,447.33万元，同比下降41.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700000565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635347797","title":"股市必读：英诺特（688253）5月13日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2635347797","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635347797?lang=zh_cn&edition=full","pubTime":"2026-05-14 01:40","pubTimestamp":1778694018,"startTime":"0","endTime":"0","summary":"截至2026年5月13日收盘，英诺特报收于56.4元，上涨5.05%，换手率2.18%，成交量2.99万手，成交额1.68亿元。来自机构调研要点：神经系统检测相关产品已获注册证，预计2026年有望实现销售收入。目前该业务收入占比较低，存在投资风险。受体外诊断行业政策监管、行业竞争以及呼吸道疾病流行趋势减弱影响，公司2026年一季度营收与利润同比下降，导致毛利率、利润及现金流指标下滑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400001382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632641729","title":"每周股票复盘：英诺特（688253）股东户数下降10.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2632641729","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632641729?lang=zh_cn&edition=full","pubTime":"2026-05-02 02:43","pubTimestamp":1777660989,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘，英诺特报收于52.05元，较上周的46.12元上涨12.86%。本周关注点股本股东变化：股东户数较上期减少10.44%，户均持股上升至2.23万股。股本股东变化股东户数变动截至2026年3月31日，公司股东户数为6140.0户，较12月31日减少716.0户，减幅为10.44%。2025年度内部控制审计报告大信会计师事务所对北京英诺特生物技术股份有限公司截至2025年12月31日的财务报告内部控制有效性进行了审计。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200000532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630306357","title":"英诺特（688253）披露2025年度募集资金存放、管理与实际使用情况专项报告，4月28日股价上涨1.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630306357","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630306357?lang=zh_cn&edition=full","pubTime":"2026-04-28 19:22","pubTimestamp":1777375378,"startTime":"0","endTime":"0","summary":"截至2026年4月28日收盘，英诺特报收于46.54元，较前一交易日上涨1.17%，最新总市值为63.75亿元。该股当日开盘44.53元，最高47.78元，最低44.02元，成交额达2.13亿元，换手率为3.36%。公司于近日披露《北京英诺特生物技术股份有限公司募集资金存放、管理与实际使用情况审核报告》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800055293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630718314","title":"图解英诺特一季报：第一季度单季净利润同比下降57.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630718314","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630718314?lang=zh_cn&edition=full","pubTime":"2026-04-28 03:26","pubTimestamp":1777318005,"startTime":"0","endTime":"0","summary":"证券之星消息，英诺特2026年一季报显示，一季度公司主营收入1.09亿元，同比下降47.43%；归母净利润4063.16万元，同比下降57.36%；扣非净利润3524.38万元，同比下降60.11%；负债率6.09%，投资收益169.73万元，财务费用0.82万元，毛利率76.36%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800010019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617663584","title":"每周股票复盘：英诺特（688253）获偏肺病毒检测试剂注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2617663584","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617663584?lang=zh_cn&edition=full","pubTime":"2026-03-08 03:09","pubTimestamp":1772910551,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，英诺特报收于34.8元，较上周的36.44元下跌4.5%。本周，英诺特3月2日盘中最高价报36.32元。本周关注点公司公告汇总：英诺特取得偏肺病毒、副流感病毒抗原联合检测试剂盒注册证。公司公告汇总北京英诺特生物技术股份有限公司近期取得1项新产品资质，获批产品为偏肺病毒、副流感病毒抗原联合检测试剂盒，注册证号国械注准20263400444，发证日期为2026年3月3日，有效期至2031年3月2日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800001095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617951245","title":"英诺特最新公告：公司新取得一项产品资质","url":"https://stock-news.laohu8.com/highlight/detail?id=2617951245","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617951245?lang=zh_cn&edition=full","pubTime":"2026-03-05 17:07","pubTimestamp":1772701622,"startTime":"0","endTime":"0","summary":"英诺特(688253.SH)公告称，公司近期新取得一项产品资质，为偏肺病毒、副流感病毒抗原联合检测试剂盒（乳胶层析法）的医疗器械注册证。该产品预期用途为用于体外定性检测口咽拭子样本中的偏肺病毒抗原、副流感病毒抗原。上述资质的取得，拓宽了公司产品的种类，进一步提高了公司的市场拓展能力及核心竞争力。但该产品的实际销售受到市场需求、市场竞争以及公司市场推广效果等多种因素影响，利润贡献具有不确定性，尚无法预测上述产品对公司未来经营业绩的影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500026924.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610045989","title":"英诺特(688253.SH)2025年度归母净利润1.46亿元 同比下降40.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610045989","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610045989?lang=zh_cn&edition=full","pubTime":"2026-02-11 15:44","pubTimestamp":1770795854,"startTime":"0","endTime":"0","summary":"智通财经APP讯，英诺特(688253.SH)发布2025年度业绩快报，报告期内，公司实现营业总收入4.22亿元，同比下降32.08%;实现归属于母公司所有者的净利润1.46亿元，同比下降40.84%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1404128.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"英诺特(688253.SH)2025年度归母净利润1.46亿元 同比下降40.84%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606751244","title":"英诺特（688253）6764.75万股限售股将于1月28日解禁，占总股本49.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606751244","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606751244?lang=zh_cn&edition=full","pubTime":"2026-01-28 08:13","pubTimestamp":1769559190,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，英诺特于1月28日将有6764.75万股限售股份解禁，为公司追加承诺限售股份上市流通，占公司总股本49.38%。本次解禁后，公司已无限售股份。英诺特主营业务：POCT快速诊断产品研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800007007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606232098","title":"每周股票复盘：英诺特（688253）49.3834%限售股1月28日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2606232098","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606232098?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:18","pubTimestamp":1769282293,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，英诺特报收于35.56元，较上周的35.43元上涨0.37%。本次上市流通的限售股数量为67,647,516股，占公司总股本的49.3834%，上市流通日期为2026年1月28日。上述股东已严格履行股份锁定承诺，保荐机构对本次限售股上市流通无异议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001157.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604251131","title":"英诺特（688253）披露首次公开发行限售股上市流通公告，1月19日股价下跌0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604251131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604251131?lang=zh_cn&edition=full","pubTime":"2026-01-19 22:48","pubTimestamp":1768834096,"startTime":"0","endTime":"0","summary":"截至2026年1月19日收盘，英诺特报收于35.26元，较前一交易日下跌0.48%，最新总市值为48.3亿元。公司近日发布公告称，北京英诺特生物技术股份有限公司首次公开发行限售股将于2026年1月28日上市流通。本次解除限售股份数量为67,647,516股，占公司总股本的49.3834%。限售股股东共5名，包括实际控制人叶逢光、张秀杰及其一致行动人控制的企业和员工持股平台。保荐机构对本次限售股上市流通无异议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900036082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2604923724","title":"每周股票复盘：英诺特（688253）预计2026年日常关联交易额600万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604923724","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604923724?lang=zh_cn&edition=full","pubTime":"2026-01-18 03:21","pubTimestamp":1768677667,"startTime":"0","endTime":"0","summary":"截至2026年1月16日收盘，英诺特报收于35.43元，较上周的32.03元上涨10.62%。本周关注点公司公告汇总：预计2026年与迁安市兴衡企业发生日常关联交易，总额600万元。预计2026年度与迁安市兴衡企业管理咨询服务有限公司发生采购商品、接受服务及房屋租赁服务等日常关联交易，合计预计金额为600万元，以市场价格为定价依据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011800000843.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603603902","title":"英诺特（688253）披露预计2026年度日常关联交易额度，1月15日股价下跌2.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603902","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603603902?lang=zh_cn&edition=full","pubTime":"2026-01-15 17:40","pubTimestamp":1768470040,"startTime":"0","endTime":"0","summary":"截至2026年1月15日收盘，英诺特报收于34.76元，较前一交易日下跌2.55%，最新总市值为47.62亿元。公司近日发布公告称，北京英诺特生物技术股份有限公司于2026年1月15日召开第二届董事会第十三次会议，审议通过《关于预计2026年度日常关联交易额度的议案》，关联董事回避表决。公告显示，公司预计2026年度与迁安市兴衡企业管理咨询服务有限公司发生采购商品、接受服务及房屋租赁服务等日常关联交易，合计预计金额为600万元，以市场价格为定价依据。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011500029302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2602535147","title":"每周股票复盘：英诺特（688253）获数字化单分子免疫分析仪资质","url":"https://stock-news.laohu8.com/highlight/detail?id=2602535147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602535147?lang=zh_cn&edition=full","pubTime":"2026-01-11 02:55","pubTimestamp":1768071310,"startTime":"0","endTime":"0","summary":"截至2026年1月9日收盘，英诺特报收于32.03元，较上周的30.18元上涨6.13%。本周，英诺特1月9日盘中最高价报32.18元。英诺特当前最新总市值43.88亿元，在医疗器械板块市值排名83/127，在两市A股市值排名3821/5182。上述产品基于单分子阵列检测技术，检测灵敏度达fg级别，可实现多种生物标志物同时检测，有助于神经系统疾病等的超早期诊断。资质的取得有助于提升公司市场拓展能力和核心竞争力。产品实际销售及业绩影响存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011100000759.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688253"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601039888","title":"英诺特（688253）披露近期获得资质情况，1月8日股价上涨2.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601039888","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601039888?lang=zh_cn&edition=full","pubTime":"2026-01-08 22:24","pubTimestamp":1767882261,"startTime":"0","endTime":"0","summary":"截至2026年1月8日收盘，英诺特报收于31.65元，较前一交易日上涨2.26%，最新总市值为43.36亿元。该股当日开盘30.86元，最高31.86元，最低30.83元，成交额达5880.66万元，换手率为2.7%。公司近日发布关于近期获得资质情况的自愿披露公告。公告显示，北京英诺特生物技术股份有限公司近期取得两项产品资质，分别为数字化单分子免疫分析仪和全自动数字化单分子免疫分析仪，注册证号均为京械注准，有效期至2030年12月30日。产品实际销售及业绩影响存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010800039006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688253","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1782930884334,"stockEarnings":[{"period":"1week","weight":0.0683},{"period":"1month","weight":0.134},{"period":"3month","weight":0.8081},{"period":"6month","weight":1.161},{"period":"1year","weight":1.1127},{"period":"ytd","weight":1.161}],"compareEarnings":[{"period":"1week","weight":0.0004},{"period":"1month","weight":0.0135},{"period":"3month","weight":0.0493},{"period":"6month","weight":0.0362},{"period":"1year","weight":0.1893},{"period":"ytd","weight":0.0362}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京英诺特生物技术股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"6140人(较上一季度减少10.44%)","perCapita":"22310股","listingDate":"2022-07-28","address":"北京市丰台区海鹰路1号院6号楼1层2层","registeredCapital":"13698万元","survey":" 北京英诺特生物技术股份有限公司的主营业务是POCT快速诊断产品研发、生产和销售。公司的主要产品是呼吸道系列、优生优育系列、其他试剂系列、POCT诊断仪器。公司获得了国家级专精特新“小巨人”企业称号。","listedPrice":26.06},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"英诺特(688253)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供英诺特(688253)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"英诺特,688253,英诺特股票,英诺特股票老虎,英诺特股票老虎国际,英诺特行情,英诺特股票行情,英诺特股价,英诺特股市,英诺特股票价格,英诺特股票交易,英诺特股票购买,英诺特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"英诺特(688253)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供英诺特(688253)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}